Your browser is no longer supported. Please, upgrade your browser.
CSBR Champions Oncology, Inc. weekly Stock Chart
CSBR [NASD]
Champions Oncology, Inc.
Index- P/E- EPS (ttm)-0.11 Insider Own20.79% Shs Outstand12.73M Perf Week-1.35%
Market Cap115.19M Forward P/E39.91 EPS next Y0.22 Insider Trans0.00% Shs Float9.97M Perf Month-2.34%
Income-1.30M PEG- EPS next Q0.00 Inst Own54.10% Short Float1.41% Perf Quarter3.17%
Sales34.90M P/S3.30 EPS this Y150.00% Inst Trans-2.86% Short Ratio6.15 Perf Half Y8.40%
Book/sh0.43 P/B20.42 EPS next Y228.36% ROA-6.90% Target Price11.00 Perf Year67.88%
Cash/sh0.53 P/C16.69 EPS next 5Y15.00% ROE-31.20% 52W Range4.02 - 10.89 Perf YTD5.40%
Dividend- P/FCF383.98 EPS past 5Y40.30% ROI-35.80% 52W High-19.38% Beta1.17
Dividend %- Quick Ratio1.10 Sales past 5Y29.40% Gross Margin47.10% 52W Low118.41% ATR0.34
Employees143 Current Ratio1.10 Sales Q/Q41.80% Oper. Margin-3.70% RSI (14)46.38 Volatility2.96% 3.99%
OptionableNo Debt/Eq0.02 EPS Q/Q109.60% Profit Margin-3.60% Rel Volume1.16 Prev Close8.83
ShortableYes LT Debt/Eq0.00 EarningsSep 14 AMC Payout- Avg Volume22.80K Price8.78
Recom2.00 SMA20-3.59% SMA500.79% SMA2006.42% Volume26,473 Change-0.57%
Nov-18-19Initiated The Benchmark Company Speculative Buy
Sep-16-20 07:27AM  
Sep-14-20 04:00PM  
Sep-08-20 04:30PM  
Jul-30-20 07:21AM  
Jul-27-20 04:01PM  
Jul-22-20 08:00AM  
Jul-15-20 03:55PM  
Jun-17-20 09:37AM  
May-27-20 07:05AM  
Apr-28-20 09:50AM  
Apr-27-20 07:20AM  
Mar-28-20 09:23AM  
Mar-16-20 09:35AM  
Mar-12-20 04:17PM  
Mar-10-20 08:30AM  
Feb-26-20 09:32AM  
Feb-18-20 05:44AM  
Feb-05-20 09:23AM  
Jan-29-20 09:00AM  
Jan-17-20 09:34AM  
Jan-13-20 06:07AM  
Dec-24-19 09:37AM  
Dec-16-19 04:00PM  
Dec-09-19 08:30AM  
Dec-08-19 08:59AM  
Dec-04-19 08:36AM  
Nov-14-19 08:53AM  
Nov-13-19 05:00PM  
Nov-12-19 07:27AM  
Oct-24-19 09:00AM  
Oct-18-19 07:41AM  
Oct-03-19 08:49AM  
Sep-25-19 12:43PM  
Sep-16-19 04:00PM  
02:30PM  
Sep-13-19 08:39AM  
Sep-09-19 08:30AM  
Sep-02-19 01:30PM  
Aug-26-19 08:37AM  
Aug-05-19 08:42AM  
Jul-29-19 06:48PM  
Jul-26-19 06:58AM  
Jul-15-19 04:35PM  
Jul-12-19 10:00AM  
Jul-02-19 09:35AM  
May-31-19 09:37AM  
May-30-19 08:30AM  
May-01-19 08:07AM  
Apr-17-19 09:49AM  
Apr-16-19 10:51AM  
Apr-01-19 08:54AM  
Mar-27-19 10:03AM  
Mar-25-19 10:42AM  
Mar-18-19 04:00PM  
Mar-06-19 08:30AM  
Mar-04-19 11:40PM  
Jan-10-19 08:43AM  
Dec-17-18 03:30PM  
03:00PM  
Dec-10-18 04:30PM  
Nov-22-18 05:45PM  
Nov-16-18 05:45PM  
Nov-15-18 07:20AM  
Nov-07-18 08:30AM  
Nov-05-18 05:45PM  
Nov-02-18 07:27AM  
Oct-29-18 09:30AM  
Oct-23-18 05:45PM  
Oct-12-18 09:30AM  
Oct-04-18 06:55AM  
Oct-01-18 12:10PM  
Sep-28-18 09:15AM  
Sep-21-18 10:00AM  
Sep-20-18 09:15AM  
Sep-13-18 04:05PM  
08:30AM  
Sep-06-18 10:59AM  
Aug-28-18 08:30AM  
Aug-08-18 08:30AM  
Jul-26-18 04:02PM  
Jul-12-18 08:30AM  
Jun-18-18 08:30AM  
May-03-18 08:30AM  
May-01-18 08:30AM  
Apr-04-18 08:30AM  
Mar-28-18 07:10AM  
Mar-15-18 04:01PM  
12:45PM  
08:46AM  
Mar-07-18 08:30AM  
Feb-27-18 07:19PM  
Feb-26-18 08:30AM  
Feb-21-18 08:30AM  
Feb-14-18 06:29PM  
Dec-29-17 05:45PM  
Dec-19-17 09:16AM  
Dec-18-17 07:40AM  
Dec-07-17 04:15PM  
06:23AM  
Nov-28-17 08:05AM  
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TOBIN SCOTT RDirectorOct 30Option Exercise5.4610,00054,60010,000Oct 30 04:36 PM
SIDRANSKY DAVIDDirectorOct 16Option Exercise5.4616,66791,002758,334Oct 28 02:53 PM
Mendelson Daniel NewmanDirectorMar 26Buy5.911,2207,21358,746Mar 30 04:56 PM
Mendelson Daniel NewmanDirectorMar 24Buy5.502614357,526Mar 26 03:00 PM
Morris RonnieCEOMar 24Sale5.2575394837,168Mar 26 02:52 PM
Morris RonnieCEOMar 20Buy4.7575356837,243Mar 24 09:54 AM
New Enterprise Associates 14, 10% OwnerMar 06Sale6.99708,1554,950,0031,713,720Mar 10 04:45 PM
ACKERMAN JOELDirectorDec 02Option Exercise2.10203,111426,5331,316,988Dec 04 04:10 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.